Andrea Dimitracopoulos
@andrea.dimitracopoulos.me
Co-Founder & Product Lead at DeepMirror | Empowering Scientists with Transformative Products | PhD in Physics & Biology
MMV and @deepmirror.bsky.social are advancing the next phase of Drug Design for Global Health (dd4gh), our open-access AI-powered drug discovery platform, with a new grant from the @gatesfoundation.bsky.social. Learn more: bit.ly/4beUFze
MMV and deepmirror continue partnership to advance AI tool for global health drug discovery | Medicines for Malaria Venture
bit.ly
Archaeaophiles! Last chance to sign up as a virtual attendee for MBoA2026. It’s cheap and you will have access to all the talks include our archaea@50 celebration with a special guest: meetings.embo.org/event/26-arc...
Molecular Biology of Archaea: Life Through the Prism of Archaea
In 1977, Woese and colleagues revealed Archaea as a distinct domain of life. Building on this insight, the discovery of Asgard archaea has strengthened the view that many hallmarks of eukaryotic cell…
meetings.embo.org
Delighted to announce increasing our total seed round to $47M, with an additional $14M investment to support further development of our targeted protein degrader portfolio. Read more: shorturl.at/DfaXn
On Thursday 25 June, Andrea Testa and Dean Clift will be in Maine presenting at the Gordon Research Conference on Induced Proximity Modalities and Therapeutics. See below for more details ⬇️
Congrats to all 2026 #KavliPrize winners, especially to five ERC grantees: 🥇Vasily Belokurov from @cam.ac.uk, Amina Helmi @rug.nl & Rodrigo Ibata @cnrs.fr in #Astrophysics 🥇Christine Holt from @cam.ac.uk & Erin Schuman @maxplanck.de in #Neuroscience. 🔗 link.europa.eu/JkJwbg @kavliprize.bsky.social
Five ERC-funded researchers among 2026 Kavli Prize laureates
Five researchers supported by the European Research Council (ERC) are among the winners of the 2026 Kavli Prize, an award that recognises advances in astrophysics, nanoscience and neuroscience.
link.europa.eu
Science really takes a village. Thrilled to share this with my friend @dudinlab.bsky.social, and with our brilliant and fearless teams, our collaborators around the world and our mentors - in my case a special shoutout to Buzz Baum, Jan Ellenberg and @monicabettencourt.bsky.social. 1/2
EMBO@embo.org · 2mo agoCongratulations to Gautam Dey (EMBL) and Omaya Dudin (University of Geneva) for being awarded the EMBO Gold Medal 2026 in recognition of their outstanding contributions to the #LifeSciences in Europe! 🧪 https://www.embo.org/press-releases/embo-gold-medal-2026-awarded-to-gautam-dey-and-omaya-dudin/
Three fully funded PhD opportunities available. Applicants from a range of academic backgrounds are encouraged to apply, but these opportunities are only available to applicants with Home fee status. Full details and how to apply: lstm.ac/studentships
This week, MMV and @dndi.org drug discovery teams came together to exchange ideas, common challenges and lessons learned across our research. From prioritizing promising compounds to advancing research in endemic countries, shared learning helps strengthen global health #innovation.
British science is behind 1 in 5 tools in the antimalarial R&D pipeline. Sustaining investment in UK malaria research could accelerate progress towards #malaria elimination while generating ripple effects across global health and economic development: bit.ly/49vc8T5
My letter to the Financial Times was published today on centralised vs devolved AI deployment. www.ft.com/content/75eb...
Letter: A mistake markets make when they value software groups
From Neil Lawrence, DeepMind Professor of Machine Learning, University of Cambridge; Chair, ai@cam, Cambridge, UK
ft.com
Our latest blog takes a behind‑the‑scenes look at the experimental and structural biology work behind #OpenBind’s first data release - from protein production to crystallographic model building and refinement. https://loom.ly/Ydcti7A #StructuralBiology #Crystallography #OpenScience
🚀 Join us for the annual Milner Pitch Day, taking place ahead of #MilnerSymp26 🗓️ 6 July ⏰ 3–6pm 📍 Jesus College, Cambridge & online This showcase highlights promising pre-Series A companies from the Milner bio-incubator, local accelerators and international partners. 🔗 https://ow.ly/kykx50YzF4J
The latest blog from #OpenBind introduces a new structure–affinity dataset for the EV‑A71 2A protease, alongside reference benchmarks and guidance on how the community can use and evaluate it across docking, co‑folding, and affinity prediction. https://loom.ly/6xPIRUc #OpenScience #DrugDiscovery #AI
We’re delighted that TRIMTECH Therapeutics won 'Start-Up of the Year' at the 2026 Cambridge Independent Science & Technology Awards! Huge thanks to our team and supporters for helping drive our mission forward. Read more: lnkd.in/dJmmd_6S
Funding opportunity for women researchers in sub-Saharan Africa. 2026 L’Oréal-UNESCO For Women in Science Programme: • PhD & postdoc (SSA) • 30 PhD + 8 postdoc grants • €10k / €15k + leadership training Deadline: 15 May 2026 Apply: bit.ly/4cXDgv6
In the latest episode of the Guardian’s Science Weekly podcast, Professor Jonathan Ball speaks to Madeleine Finlay about suspected cases of hantavirus aboard a cruise ship travelling from Argentina to Cape Verde. Listen here: www.theguardian.com/science/audi...
Hantavirus explained: how does it spread and who is most at risk? – podcast
Madeleine Finlay talks to Prof Jonathan Ball from Liverpool School of Tropical Medicine to find out more about the virus behind the outbreak on a luxury cruise ship
theguardian.com
At #RNPM26 in Brazil, MMV marked #WorldMalariaDay by discussing advances in tackling relapsing vivax #malaria. Brazil’s rollout of new tools like single-dose tafenoquine is helping redefine what’s possible for elimination.
We are deeply saddened by the passing of Dame Bridget Ogilvie, founding Chair of MMV. Her leadership helped establish MMV’s collaborative model & laid the foundation for a pipeline of antimalarials when they were needed most. Our thoughts are with her family and colleagues: bit.ly/3OVSJ70
In memory of Dame Bridget Ogilvie: Founding Chair of Medicines for Malaria Venture | Medicines for Malaria Venture
bit.ly
Today we're launching the Open Source for Science Fund, a new multi-donor philanthropic fund by Renaissance Philanthropy, seeded by @biohub.org and @wellcometrust.bsky.social, with support from @kavlifoundation.org and @researchsoftware.bsky.social 🧵 os4science.org/news/open-so...
Open Source for Science Fund Launches to Power AI-Driven Discovery
A new multi-donor fund by Renaissance Philanthropy seeded by Biohub and Wellcome opens its first call for proposals.
os4science.org
How are partnerships strengthening R&D capacity in Africa & what does this mean for #malaria? At a #WHSNairobi2026 side event, MMV & partners highlighted initiatives like RAFIKI, which is strengthening R&D in endemic countries while fostering new Africa/Europe collaborations. #WorldMalariaDay
United in the fight against #malaria and staying one step ahead of antimalarial drug resistance. Building on the momentum of #WorldMalariaDay, yesterday MMV and the RBM Partnership to End Malaria convened partners in Geneva to align and strengthen our collective response to drug resistance.
"Since 2010, the DDU malaria team, working with academic and industry partners, has been dedicated to discovering new medicines to treat and prevent malaria. One major success has been the discovery of Cabamiquine (DDD498)..." #NowWeCanNowWeMust #WorldMalariaDay #Research #EndMalaria #DDUAT20
British-backed science has helped build today’s antimalarial toolbox. Sustained support can get us closer to #ZeroMalaria. UK Parliamentarians explored tools behind progress against #malaria and innovations that can define what’s next at @malarianomoreuk.bsky.social #WorldMalariaDay event.
Children under five and pregnant women are the most at risk from malaria, accounting for the majority of the approximately 600,000 deaths each year worldwide. #NowWeCanNowWeMust #WorldMalariaDay #EndMalaria #GlobalHealth #HealthEquity #DrugDiscovery #InfectiousDiseases #PublicHealth #DDUAT20
🤍 White for health 💚 Green for prevention and awareness A small group in Geneva, part of a global team marking #WorldMalariaDay. We know this fight can be won through #partnership, #innovation and determination. #ZeroMalaria
#Malaria is preventable and treatable, yet it still takes lives every day. MMV-supported medicines have reached over 1 billion people since 1999. But the fight is changing. Drug resistance, climate pressure and funding challenges are putting progress at risk. #WorldMalariaDay
“It’s time we have the first approved and accessible African-invented antimalarial,” said MMV CEO Martin Fitchet at last year's @worldhealthsummit.bsky.social. With dd4gh, this ambition can start taking shape, expanding who gets to contribute to drug discovery 👉 bit.ly/4mdsWmI
